Radiofrequency ablation of stage IA non–small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial

Cancer6.20
Volume: 121, Issue: 19, Pages: 3491 - 3498
Published: Oct 1, 2015
Abstract
BACKGROUND This study evaluated the 2-year overall survival rate, adverse event rate, local control rate, and impact on pulmonary function tests for medically inoperable patients with stage IA non–small cell lung cancer (NSCLC) undergoing computed tomography (CT)–guided radiofrequency ablation (RFA) in a prospective, multicenter trial. METHODS Fifty-four patients (25 men and 29 women) with a median age of 76 years (range, 60-89 years) were...
Paper Details
Title
Radiofrequency ablation of stage IA non–small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial
Published Date
Oct 1, 2015
Journal
Volume
121
Issue
19
Pages
3491 - 3498
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.